Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4326)
All Articles published online
|
Jun 12, 2012 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B. Selection of RNAi-based inhibitors for anti-HIV gene therapy. World J Virol 2012; 1(3): 79-90 [PMID: 24175213 DOI: 10.5501/wjv.v1.i3.79] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v1/i3/79.htm |
| Number | Citing Articles |
| 1 |
Ying Poi Liu, Margarete Karg, Elena Herrera-Carrillo, Ben Berkhout, Xi Zhou. Towards Antiviral shRNAs Based on the AgoshRNA Design. PLOS ONE 2015; 10(6): e0128618 doi: 10.1371/journal.pone.0128618
|
| 2 |
Elena Herrera-Carrillo, Ben Berkhout. Gene Therapy for HIV and Chronic Infections. Advances in Experimental Medicine and Biology 2015; 848: 71 doi: 10.1007/978-1-4939-2432-5_4
|
| 3 |
Ben Berkhout, Ying Poi Liu. Towards improved shRNA and miRNA reagents as inhibitors of HIV1 replication. Future Microbiology 2014; 9(4): 561 doi: 10.2217/fmb.14.5
|
| 4 |
Fatima Boutimah, Julia J.M. Eekels, Ying Poi Liu, Ben Berkhout. Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors. Antiviral Research 2013; 98(1): 121 doi: 10.1016/j.antiviral.2013.02.011
|
| 5 |
Carol Crowther, Betty Mowa, Patrick Arbuthnot. SiRNA Delivery Methods. Methods in Molecular Biology 2016; 1364: 249 doi: 10.1007/978-1-4939-3112-5_20
|
| 6 |
Stefanie A. Knoepfel, Ben Berkhout. On the role of four small hairpins in the HIV-1 RNA genome. RNA Biology 2013; 10(4): 540 doi: 10.4161/rna.24133
|
| 7 |
Daniel Amsterdam. Unique natural and adaptive response mechanisms to control and eradicate HIV infection. AIMS Allergy and Immunology 2018; 2(3): 113 doi: 10.3934/Allergy.2018.3.113
|
| 8 |
Elena Herrera-Carrillo, Ying Poi Liu, Ben Berkhout. The Impact of Unprotected T Cells in RNAi-based Gene Therapy for HIV-AIDS. Molecular Therapy 2014; 22(3): 596 doi: 10.1038/mt.2013.280
|
| 9 |
Michelle J Chen, Anne Gatignol, Robert J. Scarborough. The discovery and development of RNA-based therapies for treatment of HIV-1 infection. Expert Opinion on Drug Discovery 2023; 18(2): 163 doi: 10.1080/17460441.2022.2117296
|
| 10 |
Jang-Gi Choi, Preeti Bharaj, Sojan Abraham, Hongming Ma, Guohua Yi, Chunting Ye, Ying Dang, N Manjunath, Haoquan Wu, Premlata Shankar. Multiplexing Seven miRNA-Based shRNAs to Suppress HIV Replication. Molecular Therapy 2015; 23(2): 310 doi: 10.1038/mt.2014.205
|
| 11 |
Dimitrios Vlachakis, Georgia Tsiliki, Athanasia Pavlopoulou, Maria G. Roubelakis, Spyridon Champeris Tsaniras, Sophia Kossida. Antiviral Stratagems against HIV-1 Using RNA Interference (RNAi) Technology. Evolutionary Bioinformatics 2013; 9: EBO.S11412 doi: 10.4137/EBO.S11412
|
| 12 |
Manjunath N. Swamy, Haoquan Wu, Premlata Shankar. Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS. Advanced Drug Delivery Reviews 2016; 103: 174 doi: 10.1016/j.addr.2016.03.005
|
| 13 |
Mireille Centlivre, Nicolas Legrand, Sofieke Klamer, Ying Poi Liu, Karin Jasmijn von Eije, Martino Bohne, Esther Siteur-van Rijnstra, Kees Weijer, Bianca Blom, Carlijn Voermans, Hergen Spits, Ben Berkhout. Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1. Molecular Therapy - Nucleic Acids 2013; 2: e120 doi: 10.1038/mtna.2013.48
|
| 14 |
Elena Herrera-Carrillo, Ben Berkhout, Roberto F. Speck. Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection. PLOS ONE 2017; 12(5): e0177935 doi: 10.1371/journal.pone.0177935
|
| 15 |
Roger Badia, Ester Ballana, José A Esté, Eva Riveira-Muñoz. Antiviral treatment strategies based on gene silencing and genome editing. Current Opinion in Virology 2017; 24: 46 doi: 10.1016/j.coviro.2017.04.001
|